Recro Pharma, Inc.
USD2.09
-0.01 (-0.48%)
CEO
Geraldine Henwood
IPO Date
2014-03-07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$2.07
Prev. Close
$2.10
Day Low
$2.00
Day High
$2.14
52W Low
$1.38
52W High
$3.29
Market Cap
$0.18B
Volume
0.14M
| -4.3 |
| 31 Dec 2021 | FY | 26.3% | -35.2% | -63.0% | -16.5% | 2.46 | 3.24 | -2.8 |
| 31 Dec 2020 | FY | 18.6% | -70.2% | 330.9% | -45.1% | -7.77 | 6.93 | -1.5 |
| 31 Dec 2019 | FY | 48.6% | -38.7% | 572.6% | -34.8% | -16.51 | 9.28 | -10.7 |
| 31 Dec 2018 | FY | 44.2% | -103.1% | 408.8% | -51.3% | -3.29 | 2.45 | -1.6 |
| 31 Dec 2017 | FY | 46.8% | -69.7% | -173.6% | -26.9% | 1.86 | 1.75 | -3.1 |
| 31 Dec 2016 | FY | 46.4% | -43.6% | -42.2% | -16.5% | 0.34 | 5.21 | -2.6 |
| 31 Dec 2015 | FY | 46.0% | 5.8% | 7.5% | 2.2% | 0.74 | 4.08 | 22.6 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -85.2% | -79.2% | 0.00 | 14.10 | -1.0 |
| -2.6 |
| 30 Jun 2023 | Q2 | 20.5% | -14.7% | -5.9% | -2.2% | 0.80 | 2.41 | -7.5 |
| 31 Mar 2023 | Q1 | 10.4% | -21.8% | -8.4% | -3.1% | 0.78 | 2.45 | -5.4 |
| 31 Dec 2022 | Q4 | 28.2% | -73.5% | -29.8% | -11.3% | 0.74 | 2.44 | -1.2 |
| 30 Sept 2022 | Q3 | 25.6% | -31.8% | -19.5% | -4.5% | 2.98 | 3.49 | -3.4 |
| 30 Jun 2022 | Q2 | 24.5% | -28.2% | -17.5% | -4.3% | 2.83 | 3.93 | -1.7 |
| 31 Mar 2022 | Q1 | 24.0% | -36.2% | -19.6% | -5.1% | 2.67 | 4.52 | -3.3 |
| 31 Dec 2021 | Q4 | 29.6% | -10.6% | -5.6% | -1.5% | 2.46 | 3.24 | -10.2 |
| 30 Sept 2021 | Q3 | 27.8% | -19.1% | -7.8% | -2.2% | 2.30 | 4.36 | -7.6 |